Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 8519648, 10 pages
http://dx.doi.org/10.1155/2016/8519648
Research Article

Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City

1Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, 11340 Mexico City, Mexico
2Servicio de Anatomía Patológica, Hospital Juárez de México, Secretaría de Salud, Av. Instituto Politécnico Nacional 5160, 07760 Mexico City, Mexico
3Unidad de Oncología, Hospital Juárez de México, Secretaría de Salud, Av. Instituto Politécnico Nacional 5160, 07760 Mexico City, Mexico
4Departamento de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón S/N, 11340 Mexico City, Mexico
5Laboratorio Nacional de Servicios Experimentales (LaNSE), Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional, Av. Instituto Politécnico Nacional 2508, 07360 Mexico City, Mexico

Received 4 July 2016; Accepted 28 August 2016

Academic Editor: Andréia M. Cardoso

Copyright © 2016 Luis Miguel Barajas-Castañeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. T. R. Geiger and D. S. Peeper, “Metastasis mechanisms,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1796, no. 2, pp. 293–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Bacac and I. Stamenkovic, “Metastatic cancer cell,” Annual Review of Pathology: Mechanisms of Disease, vol. 3, pp. 221–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. P. Gupta and J. Massagué, “Cancer metastasis: building a framework,” Cell, vol. 127, no. 4, pp. 679–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. O. J. Scully, B.-H. Bay, G. Yip, and Y. Yu, “Breast cancer metastasis,” Cancer Genomics and Proteomics, vol. 9, no. 5, pp. 311–320, 2012. View at Google Scholar · View at Scopus
  6. E. Hadler-Olsen, J.-O. Winberg, and L. Uhlin-Hansen, “Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets,” Tumor Biology, vol. 34, no. 4, pp. 2041–2051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. E. I. Deryugina and J. P. Quigley, “Matrix metalloproteinases and tumor metastasis,” Cancer and Metastasis Reviews, vol. 25, no. 1, pp. 9–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. L. Chaffer and R. A. Weinberg, “A perspective on cancer cell metastasis,” Science, vol. 331, no. 6024, pp. 1559–1564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. A. Smith and Y. Kang, “The metastasis-promoting roles of tumor-associated immune cells,” Journal of Molecular Medicine, vol. 91, no. 4, pp. 411–429, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. López-Otín and L. M. Matrisian, “Emerging roles of proteases in tumour suppression,” Nature Reviews Cancer, vol. 7, no. 10, pp. 800–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Noël, M. Jost, and E. Maquoi, “Matrix metalloproteinases at cancer tumor-host interface,” Seminars in Cell and Developmental Biology, vol. 19, no. 1, pp. 52–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Malemud, “Matrix metalloproteinases (MMPs) in health and disease: an overview,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1696–1701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. I. Park, J. Ni, F. E. Gerkema, D. Liu, V. E. Belozerov, and Q.-X. A. Sang, “Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor,” The Journal of Biological Chemistry, vol. 275, no. 27, pp. 20540–20544, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Khokha, A. Murthy, and A. Weiss, “Metalloproteinases and their natural inhibitors in inflammation and immunity,” Nature Reviews Immunology, vol. 13, no. 9, pp. 649–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. C. Kwaan and B. Mcmahon, “The role of plasminogen-plasmin system in cancer,” Cancer Treatment and Research, vol. 148, pp. 43–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. Crippa, “Urokinase-type plasminogen activator,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 4, pp. 690–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Cesarman-Maus and K. A. Hajjar, “Molecular mechanisms of fibrinolysis,” British Journal of Haematology, vol. 129, no. 3, pp. 307–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. F. García, S. González-Reyes, L. O. González et al., “Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer,” International Journal of Experimental Pathology, vol. 91, no. 4, pp. 324–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Malinowsky, C. Wolff, D. Berg et al., “uPA and PAI-1-related signaling pathways differ between primary breast cancers and lymph node metastases,” Translational Oncology, vol. 5, no. 2, pp. 98–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Ruifrok and D. A. Johnston, “Quantification of histochemical staining by color deconvolution,” Analytical and Quantitative Cytology and Histology, vol. 23, no. 4, pp. 291–299, 2001. View at Google Scholar · View at Scopus
  22. M. Zhang, X.-D. Teng, X.-X. Guo, Z.-G. Li, J.-G. Han, and L. Yao, “Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer,” Breast, vol. 22, no. 3, pp. 330–334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Dechaphunkul, M. Phukaoloun, K. Kanjanapradit et al., “Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer,” International Journal of Breast Cancer, vol. 2012, Article ID 290854, 10 pages, 2012. View at Publisher · View at Google Scholar
  24. S. Dawood, R. Hu, M. D. Homes et al., “Defining breast cancer prognosis based on molecular phenotypes: Results from a Large Cohort Study,” Breast Cancer Research and Treatment, vol. 126, no. 1, pp. 185–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Hines, B. Risendal, T. Byers, S. Mengshol, J. Lowery, and M. Singh, “Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women,” Journal of Women's Health, vol. 20, no. 10, pp. 1543–1550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Bourboulia and W. G. Stetler-Stevenson, “Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion,” Seminars in Cancer Biology, vol. 20, no. 3, pp. 161–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ham and A. Moon, “Inflammatory and microenvironmental factors involved in breast cancer progression,” Archives of Pharmacal Research, vol. 36, no. 12, pp. 1419–1431, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Duffy, T. M. Maguire, E. W. Mcdermott, and N. O'Higgins, “Urokinase plasminogen activator: a prognostic marker in multiple types of cancer,” Journal of Surgical Oncology, vol. 71, no. 2, pp. 130–135, 1999. View at Google Scholar · View at Scopus
  29. A. Jezierska and T. Motyl, “Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review,” Medical Science Monitor, vol. 15, no. 2, pp. RA32–RA40, 2009. View at Google Scholar · View at Scopus
  30. D. Liu, H. Guo, Y. Li, X. Xu, K. Yang, and Y. Bai, “Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis,” PLoS ONE, vol. 7, no. 2, article e31251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Andres, A. B. Edwards, and J. L. Wittliff, “Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance,” Journal of Clinical Laboratory Analysis, vol. 26, no. 2, pp. 93–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Hildenbrand and A. Schaaf, “The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion,” International Journal of Oncology, vol. 34, no. 1, pp. 15–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Schmitt, K. Mengele, A. Gkazepis et al., “Assessment of urokinase-type plasminogen activator and its inhibitor PAI-1 in breast cancer tissue: historical aspects and future prospects,” Breast Care, vol. 3, no. 2, pp. 3–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Rakic, C. Maillard, M. Jost et al., “Role of plasminogen activator-plasmin system in tumor angiogenesis,” Cellular and Molecular Life Sciences, vol. 60, no. 3, pp. 463–473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Pepper, “Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 7, pp. 1104–1117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Jackson, “Matrix metalloproteinases and angiogenesis,” Current Opinion in Nephrology and Hypertension, vol. 11, pp. 295–299, 2002. View at Google Scholar